Altria Group Work in process increased by 84.6% to $24.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 7.7%, from $26.00M to $24.00M. Over 5 years (FY 2020 to FY 2025), Work in process shows a downward trend with a -51.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $450.00M | $30.00M | $23.00M | $30.00M | $29.00M | $27.00M | $24.00M | $30.00M | $29.00M | $29.00M | $22.00M | $27.00M | $25.00M | $26.00M | $21.00M | $26.00M | $21.00M | $19.00M | $13.00M | $24.00M |
| QoQ Change | — | -93.3% | -23.3% | +30.4% | -3.3% | -6.9% | -11.1% | +25.0% | -3.3% | +0.0% | -24.1% | +22.7% | -7.4% | +4.0% | -19.2% | +23.8% | -19.2% | -9.5% | -31.6% | +84.6% |
| YoY Change | — | — | — | — | -93.6% | -10.0% | +4.3% | +0.0% | +0.0% | +7.4% | -8.3% | -10.0% | -13.8% | -10.3% | -4.5% | -3.7% | -16.0% | -26.9% | -38.1% | -7.7% |
| % of Inventories | 25.1% | 2.6% | 1.9% | 2.5% | 2.5% | 2.4% | 2.0% | 2.4% | 2.4% | 2.5% | 1.8% | 2.2% | 2.1% | 2.4% | 1.9% | 2.4% | 2.1% | 1.8% | 1.2% | 2.1% |
| Share Change | — | -22.4pp | -0.7pp | +0.5pp | +0.1pp | -0.1pp | -0.4pp | +0.4pp | +0.0pp | +0.0pp | -0.7pp | +0.4pp | -0.0pp | +0.2pp | -0.4pp | +0.5pp | -0.4pp | -0.3pp | -0.6pp | +0.9pp |